Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions
- PMID: 2839705
- PMCID: PMC253719
- DOI: 10.1128/JVI.62.8.2836-2844.1988
Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions
Abstract
Clonal cells derived from HepG2 cells transfected with a plasmid containing hepatitis B virus (HBV) DNA secrete hepatitis B surface antigen particles, nucleocapsids, and virions (M. A. Sells, M.-L. Chen, and G. Acs, Proc. Natl. Acad. Sci. USA 84:1005-1009, 1987) which elicit acute hepatitis in chimpanzees (G. Acs, M. A. Sells, R. H. Purcell, P. Price, R. Engle, M. Shapiro, and H. Popper, Proc. Natl. Acad. Sci. USA 84:4641-4644, 1987). We report here the initial characterization of the viral nucleic acids produced in this culture system. Kinetic analyses of nuclear, cytoplasmic, and extracellular HBV DNAs were performed by Southern blotting with radiolabeled HBV strand-specific probes. The results from these analyses indicate that at the stationary cellular growth phase, there is a dramatic increase in the rate at which HBV DNA accumulates. Incomplete double- and single-stranded forms of the HBV genome were detected in the nuclear and cytoplasmic fractions as well as in the extracellular medium. In addition, the nuclear DNA apparently includes multiple complete copies of the HBV genome chromosomally integrated and full-length covalently closed circular HBV DNA. Multiple HBV-specific polyadenylated RNAs with lengths of 3.5, 2.5, and 2.1 kilobases were identified by Northern (RNA) blot analysis. S1 nuclease mapping and primer extension identified a single 3' end and multiple unique initiation sites corresponding to nucleotides just 5' to the pre-S1 region, as well as upstream and within the pre-S2 and precore regions. The nucleic acid profile obtained from these analyses is essentially a facsimile of that obtained by studying liver tissue from HBV-infected individuals.
Similar articles
-
Dynamic analysis of hepatitis B virus DNA and its antigens in 2.2.15 cells.J Viral Hepat. 2004 Mar;11(2):124-9. doi: 10.1046/j.1365-2893.2003.00485.x. J Viral Hepat. 2004. PMID: 14996346
-
In vitro infection of human hepatoma (HepG2) cells with hepatitis B virus.J Virol. 1990 Jun;64(6):3025-32. doi: 10.1128/JVI.64.6.3025-3032.1990. J Virol. 1990. PMID: 2159560 Free PMC article.
-
Hepatitis B virus DNA forms in nuclear and cytoplasmic fractions of infected human liver.Virology. 1984 Sep;137(2):390-9. doi: 10.1016/0042-6822(84)90231-9. Virology. 1984. PMID: 6485254
-
Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA.Antimicrob Agents Chemother. 1999 Aug;43(8):2017-26. doi: 10.1128/AAC.43.8.2017. Antimicrob Agents Chemother. 1999. PMID: 10428929 Free PMC article.
-
Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA.World J Gastroenterol. 2018 Jun 7;24(21):2261-2268. doi: 10.3748/wjg.v24.i21.2261. World J Gastroenterol. 2018. PMID: 29881235 Free PMC article. Review.
Cited by
-
Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases.Mol Ther. 2013 Oct;21(10):1889-97. doi: 10.1038/mt.2013.170. Epub 2013 Jul 25. Mol Ther. 2013. PMID: 23883864 Free PMC article.
-
Effect of oxymatrine on the replication cycle of hepatitis B virus in vitro.World J Gastroenterol. 2010 Apr 28;16(16):2028-37. doi: 10.3748/wjg.v16.i16.2028. World J Gastroenterol. 2010. PMID: 20419842 Free PMC article.
-
Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly.Antimicrob Agents Chemother. 2013 Nov;57(11):5344-54. doi: 10.1128/AAC.01091-13. Epub 2013 Aug 19. Antimicrob Agents Chemother. 2013. PMID: 23959305 Free PMC article.
-
A potent human neutralizing antibody Fc-dependently reduces established HBV infections.Elife. 2017 Sep 26;6:e26738. doi: 10.7554/eLife.26738. Elife. 2017. PMID: 28949917 Free PMC article.
-
Re-Designed Recombinant Hepatitis B Virus Vectors Enable Efficient Delivery of Versatile Cargo Genes to Hepatocytes with Improved Safety.Viruses. 2016 May 10;8(5):129. doi: 10.3390/v8050129. Viruses. 2016. PMID: 27171107 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources